Growth Metrics

Johnson & Johnson (JNJ) Common Equity (2016 - 2025)

Historic Common Equity for Johnson & Johnson (JNJ) over the last 17 years, with Q3 2025 value amounting to $79.3 billion.

  • Johnson & Johnson's Common Equity rose 1299.78% to $79.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $79.3 billion, marking a year-over-year increase of 1299.78%. This contributed to the annual value of $71.5 billion for FY2024, which is 394.92% up from last year.
  • According to the latest figures from Q3 2025, Johnson & Johnson's Common Equity is $79.3 billion, which was up 1299.78% from $78.5 billion recorded in Q2 2025.
  • In the past 5 years, Johnson & Johnson's Common Equity ranged from a high of $79.3 billion in Q3 2025 and a low of $63.3 billion during Q1 2021
  • Over the past 5 years, Johnson & Johnson's median Common Equity value was $71.5 billion (recorded in 2024), while the average stood at $72.6 billion.
  • Its Common Equity has fluctuated over the past 5 years, first soared by 1698.06% in 2022, then tumbled by 1045.52% in 2023.
  • Quarter analysis of 5 years shows Johnson & Johnson's Common Equity stood at $70.3 billion in 2021, then rose by 6.16% to $74.6 billion in 2022, then decreased by 7.81% to $68.8 billion in 2023, then grew by 3.95% to $71.5 billion in 2024, then grew by 10.89% to $79.3 billion in 2025.
  • Its Common Equity stands at $79.3 billion for Q3 2025, versus $78.5 billion for Q2 2025 and $78.1 billion for Q1 2025.